Charles River Laboratories (CRL) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $291.45 +0.50%
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Continuing operations (in dollars per share): 0.79
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $286 million versus the consensus estimate of $286.21 million.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Largo restructures $82.2M in debt, extending maturity to 2030
- Firm Capital Apartment REIT posts Q2 loss, plans name change
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
